Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Por um escritor misterioso
Descrição
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis, European Journal of Medical Research
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines - Sette - 2022 - Immunological Reviews - Wiley Online Library
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study - The Lancet Rheumatology
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study - The Lancet Healthy Longevity
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
de
por adulto (o preço varia de acordo com o tamanho do grupo)
